Galactose, first used to assess liver function of human subjects in 1906 (1) , has retained its popularity with several generations of hepatic physiologists (2-4) because 90-95% of a test dose is metabolized in the liver (5) . The remainder is excreted in the urine or metabolized by erythrocytes (5, 6) . Hepatic metabolism rapidly converts it to glucose by way of galactokinase (EC 2.7.1.6), galactose-1-phosphate uridylyltransferase (EC 2.7.7.10), and UDPgalactose 4-epimerase (EC 5.1.3.2) (7), but the rate at which it is metabolized is a function of its concentration in plasma. In the high-concentration range (0.5 to 2 g/L), after a large intravenous bolus injection (500 mg/kg body wt.), clearance follows zero-order kinetics-i.e., the plasma concentration declines linearly with time (8)-and the rate-limiting factor is galactose metabolism in the hepatocyte.
In contrast, in the low-concentration range (<200 mg/L), clearance exhibits first-order kinetics-the concentration in plasma declines exponentially with time-and the rate-limiting factor is the rate of blood flow through the liver (4, 9) . Measurement of galactose clearance in this range of concentration in the blood was proposed (4, 5) as a method of measuring hepatic blood flow in the 1950's, but was not implemented, probably because there was no method of accurately measuring galactose in low (0-100 mg/L) concentration in the blood or plasma. The applicability of clearance methods for measuring hepatic blood flow has been limited in the past by the inability of the cirrhotic liver to extract the test compound completely during one passage through the organ. For example, if a diseased liver can extract only 5 mg of a test substance per unit of time, the extraction will be 5% when the input is 100 mg per unit of time; but if the input is decreased to 5 mg or less per unit of time, the extraction becomes 100%. 11. Wash solution.
Materials and Methods

Collection of Blood Samples
To 410 mL of demineralized water, add 50 mL of 0.5 molfL NaOH and 40 mL of reagent 10, shake, and filter. This wash solution between samples was necessary to provide a consistent background matrix of the same composition as the samples. We used the smaller volume of ZnSO4 because 20% less ZnSO4 precipitates from aqueous solution than from serum when equal volumes of ZnSO4 and NaOH are used (17) .
Procedure
Analyze the clear deproteinized filtrate by continuous-flow (see Figure 1 ), using two coupled enzymic reactions. The limiting reaction is the specific oxidation of galactose by galactose oxidase:
In the second reaction p-hydroxyphenylacetic acid acts as hydrogen donor for the peroxidase reaction; the product of this oxidation is fluorescent: p-Hydroxyphenylacetic acid + H202
fluorescent compound + 2H20.
The manifold (Figure 1) 
Analytical Variables
Recovery and precision were evaluated as follows. Plasma test samplescontaining expected concentrations of 10,40, 70, and 100 mgfL were prepared by adding galactose to plasma from fasted subjects. Blood (100 mL) was drawn (with fluoride anticoagulant), and the plasma was separated, divided into five aliquots for multiple assay on different days, and stored at -20 #{176}C until analysis. On each of five days, samples from each concentration were assayed in duplicate, four times in each run. Hence, 40 assays were performed on each galactose concentration.
Between-duplicate precision, within-run precision, and day-to-day precision were assessed from these multiple analyses. CV's from sample-to-sample ranged from 1.2 to 7.7%, within-run from 2.1 to 8.6%, and day-to-day from 2.2 to 17.2%. The largest CV's were at the 10 mg/L concentration; the smallest were at the 70 or 100 mg/L concentration.
Results
For
Illustrative Galactose Infusion Studies (Figure 2)
This shows the plasma galactose concentrations during infusion of 50 g/L galactose in a normal and a cirrhotic subject. The infusion rate was 60 mg of galactose per minute; a steady-state plasma concentration was reached at 80 mm. In the cirrhotic patient, plasma galactose plateaued at 96 mg of galactose per liter; in the normal subject, the plateau concentration was 48 mg/L. Calculate the galactose clearance from the equation Clearance was 1250 mL/min in the normal subject, and 630 mL/min in the cirrhotic patient. Reports on a series of such studies will be published elsewhere.
Discussion
Some Problems and Their Solution
In attempting the transition from measuring high concentrations of galactose in small samples, as described by Mason (15) , to small concentrations in large samples, we identified two problems: interfering substances in blood totally inhibited the enzyme reaction in untreated samples, and the fluorometric method as previously described (15) was inadequately sensitive.
The principal substance in plasma interfering with the enzyme reactions was uric acid; analogous problems were encountered by Kreutzer (19) in the glucose oxidase/peroxidase determination of blood glucose. In whole blood, the most significant interfering substance was glutathione (17) .
Initially, we attempted to remove these compounds with ion-exchange resins, an approach useful in measuring low concentrations of glucose in urine (20, 21) . The interfering substances were removed by a strongly basic resin, with only a twofold sample dilution, but the method was tedious and only semiquantitative.
We could totally remove the interfering substances by alkali deproteinization with a heavy metal salt (16) Hemolysis and hyperbilirubinemia frequently interfere with both colorimetric and fluorometric analysis. These presented potential problems with our method, because fluoride/oxalate produces some hemolysis, and some of our patients with liver disease show hyperbilirubinemia.
ZnSO4/NaOH precipitates both hemoglobin and bilirubin from plasma, and we have had satisfactory recovery studies with serum bilirubin as high as 300 mg/L. clearance studies, infusing 50-100 mg of galactose per minute, this metabolism amounts to 1 to 2% of galactose clearance.
Advantages
Galactose concentrations can now be measured in blood or plasma in the 0-100 mg/L range. This opens the way to more extensive evaluation of the clearance of galactose from blood at these concentrations, and hence the measurement of nutrient hepatic blood flow.
Addendum
Since 
